Pages that link to "Q33685309"
Jump to navigation
Jump to search
The following pages link to Standardized methods for the production of high specific-activity zirconium-89. (Q33685309):
Displaying 50 items.
- Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with 89Zr-7E11 Immuno-PET (Q24633858) (← links)
- Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging (Q26865516) (← links)
- Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas (Q27335251) (← links)
- Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes (Q28384090) (← links)
- A recommendation for revised dose calibrator measurement procedures for 89Zr and 124I (Q28542889) (← links)
- Cerenkov luminescence imaging of medical isotopes (Q30499280) (← links)
- Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model (Q30525314) (← links)
- Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET (Q30643770) (← links)
- Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab (Q33527397) (← links)
- Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles (Q33691661) (← links)
- Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO). (Q33761754) (← links)
- Hybrid PET-optical imaging using targeted probes (Q33842703) (← links)
- Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal [...] (Q33995700) (← links)
- Rational design, synthesis, and evaluation of tetrahydroxamic acid chelators for stable complexation of zirconium(IV) (Q34009558) (← links)
- Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals (Q34119201) (← links)
- 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging (Q34228306) (← links)
- CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma (Q34342934) (← links)
- Quantitative imaging of disease signatures through radioactive decay signal conversion (Q34369413) (← links)
- 89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo. (Q34389457) (← links)
- Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions (Q34460892) (← links)
- Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives (Q34473460) (← links)
- Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts (Q34473478) (← links)
- Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology (Q34762185) (← links)
- Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer (Q34813272) (← links)
- Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions (Q34876852) (← links)
- Imaging the L-type amino acid transporter-1 (LAT1) with Zr-89 immunoPET (Q35021768) (← links)
- MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides (Q35109294) (← links)
- Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry (Q35394166) (← links)
- Novel (89)Zr cell labeling approach for PET-based cell trafficking studies (Q35462110) (← links)
- The next generation of positron emission tomography radiopharmaceuticals in oncology. (Q35525690) (← links)
- Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105. (Q35587248) (← links)
- (89)Zr-Oxine Complex PET Cell Imaging in Monitoring Cell-based Therapies (Q35684967) (← links)
- Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89. (Q35865849) (← links)
- Nanoparticles labeled with positron emitting nuclides: advantages, methods, and applications (Q35897573) (← links)
- In vivo biodistribution and accumulation of 89Zr in mice (Q35923622) (← links)
- Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen. (Q35956405) (← links)
- ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW. (Q36185354) (← links)
- Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma (Q36383709) (← links)
- Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. (Q36406701) (← links)
- Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer. (Q36435260) (← links)
- Multifunctional MRI/PET Nanobeacons Derived from the in Situ Self-Assembly of Translational Polymers and Clinical Cargo through Coalescent Intermolecular Forces (Q36436501) (← links)
- PET imaging with ⁸⁹Zr: from radiochemistry to the clinic (Q36454584) (← links)
- Annotating MYC status with 89Zr-transferrin imaging (Q36464891) (← links)
- (89)Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer (Q36625800) (← links)
- Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas. (Q36799494) (← links)
- In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores. (Q36909826) (← links)
- ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer. (Q36980480) (← links)
- Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications (Q37022385) (← links)
- Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. (Q37024507) (← links)
- Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals (Q37026964) (← links)